These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 22476616

  • 1. Comorbidity, hypoglycaemia and appropriate selection of antidiabetic pharmacotherapy in diabetic patients with heart failure in clinical practice in Germany. Results of the DiaRegis registry.
    Gitt AK, Bramlage P, Binz C, Krekler M, Deeg E, Tschöpe D.
    Herz; 2012 May; 37(3):294-300. PubMed ID: 22476616
    [Abstract] [Full Text] [Related]

  • 2. Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registry.
    Tschöpe D, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Gitt AK.
    Cardiovasc Diabetol; 2011 Jul 14; 10():66. PubMed ID: 21756359
    [Abstract] [Full Text] [Related]

  • 3. Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry.
    Gitt AK, Bramlage P, Binz C, Krekler M, Plate T, Deeg E, Tschöpe D, DiaRegis Study Group.
    Eur J Prev Cardiol; 2012 Aug 14; 19(4):765-72. PubMed ID: 21628353
    [Abstract] [Full Text] [Related]

  • 4. Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.
    Bramlage P, Binz C, Gitt AK, Krekler M, Plate T, Deeg E, Tschöpe D.
    Cardiovasc Diabetol; 2010 Sep 16; 9():53. PubMed ID: 20843379
    [Abstract] [Full Text] [Related]

  • 5. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.
    Liu SC, Tu YK, Chien MN, Chien KL.
    Diabetes Obes Metab; 2012 Sep 16; 14(9):810-20. PubMed ID: 22486990
    [Abstract] [Full Text] [Related]

  • 6. Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up.
    Bramlage P, Gitt AK, Schneider S, Deeg E, Tschöpe D, DiaRegis Study Group.
    BMC Cardiovasc Disord; 2014 Nov 19; 14():162. PubMed ID: 25410473
    [Abstract] [Full Text] [Related]

  • 7. Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus.
    Tschöpe D, Bramlage P, Schneider S, Gitt AK.
    Diab Vasc Dis Res; 2016 Jan 19; 13(1):2-12. PubMed ID: 26567123
    [Abstract] [Full Text] [Related]

  • 8. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004 Jan 19; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 9. Increase in the incidence of severe hypoglycaemia in people with Type 2 diabetes in spite of new drugs: analysis based on health insurance data from Germany.
    Müller N, Lehmann T, Gerste B, Adler JB, Kloos C, Hartmann M, Kramer G, Kuniss N, Müller UA.
    Diabet Med; 2017 Sep 19; 34(9):1212-1218. PubMed ID: 28586530
    [Abstract] [Full Text] [Related]

  • 10. [Diabetes mellitus and heart failure: epidemiology and therapy].
    Pfister R, Erdmann E.
    Herz; 2008 Apr 19; 33(3):178-83. PubMed ID: 18568311
    [Abstract] [Full Text] [Related]

  • 11. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT, Chang KC, Li CY, Wu JS.
    Cardiovasc Diabetol; 2016 Mar 01; 15():41. PubMed ID: 26932742
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Mar 01; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry.
    Tschöpe D, Bramlage P, Binz C, Krekler M, Deeg E, Gitt AK.
    BMC Endocr Disord; 2012 Oct 17; 12():23. PubMed ID: 23075070
    [Abstract] [Full Text] [Related]

  • 20. Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care.
    Hippisley-Cox J, Coupland C.
    BMJ; 2016 Jul 12; 354():i3477. PubMed ID: 27413012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.